Akkermansia muciniphila is a gut bacterium that helps maintain the gut barrier. Here's what we know so far:
Your gut barrier is a lining made of cells and a protective mucus layer, and it’s shared territory between your body and your microbes. It lets nutrients in, keeps unwanted substances out, and gives beneficial bacteria like Akkermansia muciniphila a place to live.
Discovered in 2004, Akkermansia is a promising bacterium linked to the gut barrier and metabolic health [1], [2]. Yet, the connection between Akkermansia and weight loss is more nuanced than popular claims suggest [3], [4].
This article highlights what we know about Akkermansia's role in gut health. We’ll explore how it supports the gut barrier and what the research says about its benefits. You’ll also learn how to boost healthy levels and track them with gut microbiome testing.
Akkermansia muciniphila is a gut bacterium that feeds on the mucus that lines the intestines [1]. Research shows this bacterium may influence key aspects of health, including metabolic and immune function [5]. Yet levels vary widely from person to person, and evidence of its benefits remains limited [6].
| Aspect | What to know | Why it matters |
|---|---|---|
| Where it lives | Mucus layer lining the colon | Close contact with the gut barrier |
| What it feeds on | Mucin, the proteins in gut mucus | In mouse studies, supplementation with Akkermansia has been associated with an increased number of mucus-making cells and a thicker mucus layer [5] |
| Typical amount in the gut | Makes up 0–4% of total gut bacteria in adults; how many people carry it varies by population [7] | No established “ideal” amount, but lower levels have been associated with certain health conditions [8], [9] |
While a bacterium that breaks down mucus proteins sounds problematic, it can actually be a good thing. In mice, Akkermansia is often linked to more mucus-making cells and a thicker mucus layer, though it seems to need other microbes around to do this [10]. In lab studies, the way Akkermansia breaks down mucin also feeds other helpful bacteria [11]. These friendly bacteria can produce short-chain fatty acids (SCFAs), including acetate and butyrate, which may support mucus production and provide energy to intestinal cells. Mouse studies also suggest that Akkermansia may protect against increased intestinal permeability (a.k.a., leaky gut) by supporting the gut’s protective mucus layer. However, in mice on a low-fiber diet, high Akkermansia levels were linked to a thinner mucus layer (more on that below).
What Akkermansia does in the gut:
Studies on the benefits of Akkermansia in the gut are relatively new, with most findings from small early human trials or animal and in vitro data. Currently, most are associations. These studies don't necessarily prove that Akkermansia protects against certain conditions. They also don't explain how Akkermansia might produce a specific outcome. Not all studies are designed the same way, so results may differ.
| Area | Potential link | Evidence so far |
|---|---|---|
| Metabolic health | Linked to better insulin sensitivity [15] | Human observational study: Reduced risk of metabolic syndrome with increased abundance of Akkermansia [16] Human intervention study (pasteurized Akkermansia muciniphila): No difference in whole-body insulin sensitivity between Akkermansia muciniphila supplementation versus placebo [3] |
| Weight management | Higher levels associated with lower obesity risk | Human observational study: A higher share of Akkermansia among total gut bacteria (relative abundance) correlated with low obesity risk [6] Human interventional study: Akkermansia linked to healthier metabolic status after calorie restriction in adults who are overweight or obese [15] |
| Gut-brain signaling | Molecules produced may influence gut-brain communication | In vitro study: Akkermansia produces GABA in acidic conditions [17] Mouse study: Giving Akkermansia together with Parabacteroides protected mice from seizures [18] Mouse study: Ketogenic diet was associated with Akkermansia and anti-seizure effect [18] |
| Inflammation | Short-chain fatty acids have anti-inflammatory properties [19] | In vitro study: Produces the short-chain fatty acids acetate and propionate [1] Mouse study: Supplementation of Akkermansia improved intestinal inflammation in mice with chronic colitis depending on strain [20] |
Akkermansia levels in the gut microbiome vary widely from person to person, and some tests can’t pick up very low amounts [6], [8]. Many adults have low or undetectable levels, and while a Tiny Health Gut Health Test will flag this as out of range, it doesn’t mean your gut barrier is unprotected. Microbial diversity in the gut means that no single species is responsible for gut barrier integrity. Other bacteria can do some of the same jobs: they also produce helpful metabolites, strengthen tight junctions, and support the mucus layer [19], [21], [22].
Don’t focus solely on raising your Akkermansia levels. Instead, there may be underlying factors contributing to low Akkermansia levels.
| Factor | How it may influence Akkermansia |
|---|---|
| Ultra-processed diet | Linked to lower Akkermansia and mucus layer disruption |
| Metabolic concerns | Associated with lower levels of Akkermansia, but doesn’t necessarily establish causality [6], [8], [16] |
| Ongoing gut inflammation | Changes the mucus Akkermansia feeds on [23] |
You won't find Akkermansia in food. Instead of focusing on a single source to boost Akkermansia, here are dietary and lifestyle tips that can help create the right conditions to fuel its growth. These changes may help support Akkermansia levels, but studies on this are relatively new.
| Food group | Examples | Why it may increase Akkermansia growth |
|---|---|---|
| Polyphenol-rich fruits | Cranberries, pomegranate, grapes | Pomegranate extract increased Akkermansia in some people, while polyphenol-rich diets showed similar effects in mice [24], [25]. |
| Prebiotic fibers | Chicory root, Jerusalem artichokes, garlic, onion | Inulin, a fiber in chicory root, increased Akkermansia in adults with diabetes [25]. |
| High-FODMAP foods | Garlic, apples, whole wheat bread, legumes, milk | A low-FODMAP diet reduced Akkermansia in trials, suggesting fermentable carbs may support its growth [25]. |
Beyond food, lifestyle factors can also help support healthy Akkermansia levels. Many of these studies are associative and don't necessarily prove causality:
Akkermansia’s relationship with our health is nuanced. Mucus degradation can thin the mucus layer. This can expose intestinal cells to disruptive substances and unfriendly bacteria [10]. Mice over-colonized with Akkermansia have thinner mucus layers and a weakened intestinal barrier [30]. In mice on a low-fiber diet, high Akkermansia levels were linked to a thinner mucus layer and other downsides [10]. Fiber provides the resources needed to maintain the mucus layer. Studies have found that Akkermansia in mice on a low-fiber diet worsened food allergy symptoms [31].
Whether Akkermansia helps or hurts may depend on how much fiber you eat.
If you're considering an Akkermansia supplement or probiotic, there are a few things to know. Compared to other probiotics, it’s newer, and the research is still growing. In one trial, a live Akkermansia supplement settled into the gut mainly in people who started with low levels, and only that group saw benefits [4]. Pasteurized Akkermansia is no longer alive, so it can't colonize your gut. Still, it showed some benefits in early trials [3], [32]. Below is emerging research on different types of Akkermansia supplements and their potential as a next-generation probiotic.
| Type | Intervention period | What to consider |
|---|---|---|
| Pasteurized Akkermansia | 24 weeks | Randomized placebo-controlled trial: Supplementation reduced weight regain over 24 weeks in adults who were overweight/obese who had previously lost weight [33] |
| Pasteurized Akkermansia | 12 weeks | Randomized placebo-controlled trial: Improved insulin sensitivity and lowered blood insulin and total cholesterol in those who were overweight/obese [32] |
| Pasteurized Akkermansia | 16 weeks | Randomized placebo-controlled trial: Whole-body insulin sensitivity did not differ with Akkermansia in adults with metabolic syndrome. People with low baseline Akkermansia showed improved insulin sensitivity and higher GLP-1 production [3] |
| Live Akkermansia probiotics | 12 weeks | Randomized placebo-controlled trial: In people with type 2 diabetes who were overweight or obese, changes in body weight, fat mass, and HbA1c (a marker of average blood sugar over two to three months) depended on their baseline Akkermansia levels [4] |
A stool-based microbiome test can tell you whether you have Akkermansia in your gut and its relative abundance, or how much of your total gut bacteria it makes up. Adult gut microbiomes are relatively stable, so a single test reflects your microbiome over a period of time, not something that changes meal to meal or day to day. By testing over time, you can see how your Akkermansia levels trend. Stool reflects what’s moving through your gut rather than an exact snapshot of the gut lining. Still, it offers a valuable, noninvasive look at Akkermansia alongside the rest of your microbial community.
Testing your Akkermansia level with an at-home gut microbiome test is straightforward. With a membership, you can test before and after implementing dietary or lifestyle changes to see your progress.
Tiny Health tests and reports are provided for wellness and educational purposes only and are not intended to diagnose, treat, or cure any disease. Always consult your practitioner about any medical concerns or diagnoses, and before making changes to your diet, supplements, or treatment plan.
Akkermansia levels only tell part of the story. Low (or no) Akkermansia by itself won’t explain your digestive symptoms and is not a diagnosis. If you have persistent symptoms that feel serious, check with your healthcare practitioner rather than relying on dietary or supplementary changes and test results alone.
When to seek help:
If you have IBD, a weakened immune system, or are pregnant, check with your health practitioner before starting an Akkermansia supplement.
.avif)
Dr. Jennifer Tsang is a microbiologist turned freelance science writer with 15+ years of experience in microbiology research and science communication.
Dr. Harold Nunez, a Medical Technologist and Ph.D. holder, specializes in microbiome research with over 10 years of experience.
[1] M. Derrien, et al., “Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium,” Int. J. Syst. Evol. Microbiol., vol. 54, no. 5, pp. 1469–1476, Sep. 2004, doi: 10.1099/ijs.0.02873-0.
[2] P. D. Cani, et al., “Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms,” Nat. Rev. Gastroenterol. Hepatol., vol. 19, no. 10, pp. 625–637, Oct. 2022, doi: 10.1038/s41575-022-00631-9
[3] P. Suenaert, et al., “Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels,” Gut Microbes, vol. 18, no. 1, doi: 10.1080/19490976.2026.2690689.
[4] Y. Zhang et al., “Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut,” Cell Metab., vol. 37, no. 3, pp. 592-605.e6, Mar. 2025, doi: 10.1016/j.cmet.2024.12.010.
[5] W. M. de Vos, “Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa,” Microbiology, vol. 163, no. 5, pp. 646–648, May 2017, doi: 10.1099/mic.0.000444.
[6] Q. Zhou et al., “Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project,” Nutr. Metab., vol. 17, no. 1, p. 90, Oct. 2020, doi: 10.1186/s12986-020-00516-1.
[7] A. Ioannou et al., “Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential,” Nat. Rev. Microbiol.. vol. 23, pp. 162-177, Oct. 2024, doi: 10.1038/s41579-024-01106-1.
[8] M.C. Dao, et al., “Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement Am. J. Physiol. - Am. Physiol. Soc., vol. 317, no. 3, pp. E446-E459, Apr. 2019, doi: 10.1152/ajpendo.00140.2019.
[9] H. Earley, et al., “The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis,” Sci. Rep., vol. 9, no. 1, p. 15683, Oct. 2019, doi: 10.1038/s41598-019-51878-3.
[10] A. M. Tingler, M. A. Engevik, “Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?” Infect. and Immun., vol. 93, no. 9, p. e00503-24, doi: 10.1128/iai.00503-24.
[11] L. W. Chia et al., “Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach,” Antonie Van Leeuwenhoek, vol. 111, no. 6, pp. 859–873, Jun. 2018, doi: 10.1007/s10482-018-1040-x.
[12] T. Paradis, et al., “Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells,” Int. J. Mol. Sci., vol. 22, no. 5, p. 2506, Jan. 2021, doi: 10.3390/ijms22052506.
[13] S. H. Lee, “Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases.” Intest. Res., vol. 13, no. 1, pp. 11-18, Jan. 2015, doi: 10.5217/ir.2015.13.1.11.
[14] C. Chelakkot, et al., “Mechanisms regulating intestinal barrier integrity and its pathological implications,” Exp. Mol. Med., vol. 50, no. 8, pp. 1–9, Aug. 2018, doi: 10.1038/s12276-018-0126-x.
[15] M. C. Dao et al., “Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology,” Gut, vol. 65, no. 3, pp. 426–436, Mar. 2016, doi: 10.1136/gutjnl-2014-308778.
[16] Q. Zhou, et al., “Association Between Gut Akkermansia and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study.” Diabetes, Metab. Syndr. Obes.: Targets Ther., vol. 14, pp. 2177–2188, May 2021, doi: 10.2147/DMSO.S311388.
[17] P. Konstanti, et al., “Physiology of γ-aminobutyric acid production by Akkermansia muciniphila,” Appl. Environ. Microbiol., vol. 19, pp. e01121-23, Dec. 2023, doi: 10.1128/aem.01121-23.
[18] C. A. Olson et al., “The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet,” Cell, vol 173, no. 7, pp. 1728-1741, Jun. 2018, doi: 10.1016/j.cell.2018.04.027.
[19] J. Zhang et al., “Primary Human Colonic Mucosal Barrier Crosstalk with Super Oxygen-Sensitive Faecalibacterium prausnitzii in Continuous Culture,” Med, vol. 2, no. 1, pp. 74-98.e9, Jan. 2021, doi: 10.1016/j.medj.2020.07.001.
[20] R. Zhai et al., “Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice,” Front. Cell. Infect. Microbiol., vol. 9, Jul. 2019, doi: 10.3389/fcimb.2019.00239.
[21] N. Mohebali, et al.,“Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro,” Nutrients, vol. 12, no. 8, p. 2251, Jul. 2020, doi: 10.3390/nu12082251.
[22] M. A. Engevik et al., “Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways,” mBio, vol. 10, no. 3, p. 10.1128/mbio.01087-19, Jun. 2019, doi: 10.1128/mbio.01087-19.
[23] V. Singh et al., “Chronic Inflammation in Ulcerative Colitis Causes Long-Term Changes in Goblet Cell Function,” Cell. Mol. Gastroenterol. Hepatol., vol. 13, no. 1, pp. 219–232, Jan. 2022, doi: 10.1016/j.jcmgh.2021.08.010.
[24] C.B. Van Buiten et al., “Dietary Polyphenols Support Akkermansia muciniphila Growth via Mediation of the Gastrointestinal Redox Environment,” Antioxidants, vol. 13, no. 3, p. 304, Feb. 2024, doi: 10.3390/antiox13030304.
[25] S. Verhoog et al., “Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: a systematic review,” Nutrients, vol. 11, no. 7, p. 1565, Jul. 2019, doi: 10.3390/nu11071565.
[26] Z. Zhang, et al., “Intermittent Fasting and Probiotics for Gut Microbiota Modulation in Type 2 Diabetes Mellitus: A Narrative Review,” Nutrients, vol. 18, no. 1, p. 119, Jan. 2026, doi: 10.3390/nu18010119.
[27] C. Özkul, et al., “Islamic fasting leads to an increased abundance of Akkermansia muciniphila and Bacteroides fragilis group: A preliminary study on intermittent fasting,” Turk. J. Gastroenterol., vol. 30, no. 12, pp. 1030–1035, Dec. 2019, doi: 10.5152/tjg.2019.19185.
[28] S. S. Aguiar, et al., “Effects of physical exercise on Akkermansia muciniphila: a systematic review of human and animal studies,” Benefic. Microbes, vol. 15, no. 6, pp. 565–587, Aug. 2024, doi: 10.1163/18762891-bja00031.
[29] D. Rondinella et al., “The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier,” Nutrients, vol. 17, no. 5, p. 859, Jan. 2025, doi: 10.3390/nu17050859.
[30] S. Qu, et al., “Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment,” Front. Microbiol., vol. 14, p. 1111911, Mar. 2023, doi: 10.3389/fmicb.2023.1111911.
[31] A. Parrish, et al.,“Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice,” Nat. Micro., vol. 8, pp. 186301879, Sep. 2023, doi: 10.1038/s41564-023-01464-1.
[32] C. Depommier et al., “Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study,” Nat. Med., vol. 25, no. 7, pp. 1096–1103, Jul. 2019, doi: 10.1038/s41591-019-0495-2.
[33] S. Mount et al., “Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial,” Nat. Med., vol. 32, no. 6, pp. 2107–2116, Jun. 2026, doi: 10.1038/s41591-026-04394-7.
[34] M. C. Collado, et al., “Intestinal Integrity and Akkermansia muciniphila, a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly,” Appl. Environ. Microbiol., vol. 73, no. 23, pp. 7767-7770, doi: 10.1128/AEM.01477-07.
[35] R. Filardi, et al., “Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin,” Sci. Rep., vol. 12, no. 1, p. 19426, Nov. 2022, doi: 10.1038/s41598-022-23980-6.
[36] D. Sun et al., “Lacidophilin tablets alleviate constipation through regulation of intestinal microflora by promoting the colonization of Akkermansia sps,” Sci. Rep., vol. 14, no. 1, p. 7152, Mar. 2024, doi: 10.1038/s41598-024-57732-5.
[37] F. Asnicar et al., “Blue poo: impact of gut transit time on the gut microbiome using a novel marker,” Gut, vol. 70, no. 9, pp. 1665-1674, Aug. 2021, doi: 10.1136/gutjnl-2020-323877.
